Autologous conditioned serum for degenerative diseases and prospects
Autologous conditioned serum for degenerative diseases and prospects
نویسندگان: سید کاظم شکوری بیلانکوهی , صنم دولتی
کلمات کلیدی: Interleukin-1 receptor antagonist, autologous conditioned serum, growth factor, degenerative disease, inflammatory diseases
نشریه: 13178 , 1-6 , 39 , 2021
| نویسنده ثبت کننده مقاله |
صنم دولتی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
طب فیزیکی وتوانبخشی |
| کد مقاله |
77572 |
| عنوان فارسی مقاله |
Autologous conditioned serum for degenerative diseases and prospects |
| عنوان لاتین مقاله |
Autologous conditioned serum for degenerative diseases and prospects |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Review Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Autologous conditioned serum (ACS) is a blood-derived product that is prepared by the incubation of whole blood with medical-grade glass beads, resulting in serum enrichment in interleukin-1 receptor antagonist (IL-1Ra), anti-inflammatory cytokines (IL-4, IL-10, and IL-13), and high concentrations of growth factors. ACS has shown qualitatively and quantitatively better therapeutic effects than most established pharmacological treatments and surgery for joint diseases given its ability to both target the inflammatory cascade to decrease cartilage destruction as well as improve endogenous repair mechanisms. ACS application is simple and safe with limited adverse effects. This article reviews the role of ACS in degenerative joint disease, in addition to other inflammatory and autoimmune diseases, given its regenerative and immune-modulating properties. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Autologous conditioned serum for degenerative.pdf | 1401/02/22 | 1587801 | دانلود |